Analysts Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $80.67

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned an average recommendation of “Moderate Buy” from the eighteen brokerages that are presently covering the stock, MarketBeat reports. Nine equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $80.2105.

Several analysts have issued reports on GEHC shares. Oppenheimer reissued an “outperform” rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Rothschild & Co Redburn decreased their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. The Goldman Sachs Group downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $81.00 to $65.00 in a research note on Thursday, April 30th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Morgan Stanley raised their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th.

Insiders Place Their Bets

In other news, Director Watkin Phoebe L. Yang acquired 1,000 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the completion of the purchase, the director directly owned 13,702 shares in the company, valued at approximately $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Frank R. Jimenez purchased 1,750 shares of the firm’s stock in a transaction dated Thursday, April 30th. The shares were bought at an average cost of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider directly owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This represents a 1.90% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 11,847 shares of company stock valued at $719,555 over the last quarter. Corporate insiders own 0.36% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

Several institutional investors and hedge funds have recently modified their holdings of GEHC. Auto Owners Insurance Co raised its stake in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares in the last quarter. Norges Bank bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $596,024,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $533,655,000. Capital Research Global Investors raised its stake in shares of GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after acquiring an additional 4,998,154 shares in the last quarter. Finally, Cynosure Group LLC raised its stake in shares of GE HealthCare Technologies by 21,045.4% during the fourth quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock valued at $358,055,000 after acquiring an additional 4,344,817 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.2%

GEHC opened at $64.23 on Monday. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The firm has a market cap of $29.22 billion, a P/E ratio of 15.37, a P/E/G ratio of 1.45 and a beta of 0.74. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The stock has a 50-day moving average of $68.45 and a 200 day moving average of $76.24.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts forecast that GE HealthCare Technologies will post 4.89 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.